Menopause 
Welcome,         Profile    Billing    Logout  

2 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Menopause
NCT00493532: A Study of Quarterly Intravenous Bonviva (Ibandronate) in Women With Post-Menopausal Osteoporosis.

No Longer Available
N/A
RoW
ibandronate [Bonviva/Boniva]
Hoffmann-La Roche
Postmenopausal Osteoporosis
12/10
12/10
NCT02142868: Expanded Access Study Of Palbociclib (PD-0332991) In Combination With Letrozole As Treatment Of Post-Menopausal Women With HR-Positive, Her2-Negative Advanced Breast Cancer For Whom Letrozole Therapy Is Deemed Appropriate

No Longer Available
N/A
Canada, US
Palbociclib, Ibrance, Letrozole, Femara
Pfizer
Advanced Breast Cancer (Female)
 
 

Download Options